Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM)
This study has been completed.
Study NCT00000556 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received on October 27, 1999. Last Updated on December 1, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arrhythmia
Atrial Fibrillation
Cardiovascular Diseases
Heart Diseases
Additional conditions recognized in this trial
Arrhythmias, Cardiac
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
amiodarone
sotalol
propafenone
flecainide
quinidine
moricizine
disopyramide
procainamide
adrenergic beta antagonists
verapamil
diltiazem
digoxin
catheter ablation
pacemaker, artificial
Additional drug interventions recognized in this trial
Adrenergic Agents
Adrenergic beta-Antagonists
More general drug interventions related to this trial
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Anti-Arrhythmia Agents
Anti-Infective Agents
Antihypertensive Agents
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Autonomic Agents
Calcium Channel Blockers
Cardiotonic Agents
Cardiovascular Agents
Cholinergic Agents
Cholinergic Antagonists
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
